1m

Name: 1m
Brand: 1m

AI Native

The Standard Risk Management Framework for Healthcare

Est 2022|Raised $12.7M|4 Ref Customers

LinkedIn 801|Web traffic 1K|FTEs 23|HQ New York, New York, US

MarketsEnterprise Risk Management (ERM)

01Competitive Landscape

Narrative competitive analysis

- Potential advantages for 1m: the vendor’s healthcare-specific dataset and the framing of risk in financial and strategic terms could differentiate the product when compared with generic GRC platforms, particularly for functions focused on finance and strategy alignment. - Where alternatives may have advantages: established GRC platforms often publish more detailed security documentation, have larger numbers of third-party reviews, broader framework coverage, and more extensive partner ecosystems.

Market adoption signals

Publicly visible adoption signals for 1m are primarily the named health-system participants cited in early funding materials and vendor messaging about a networked approach to risk intelligence. Public data is insufficient to estimate market share.

	1m	LogicGate Risk Cloud	Diligent (GRC platform family)
Starting Price	Not publicly disclosed (enterprise quote)	Not publicly disclosed (custom pricing on request)	Not publicly disclosed (quote-based for enterprise GRC suites)
Intended For	Health systems seeking healthcare-specific risk intelligence and quantified exposure linked to finance/strategy	Organizations seeking configurable GRC workflows across industries; users who want customizable applications	Organizations requiring a broad governance, risk, and compliance suite integrated with board governance and audit workflows
Key Differentiator	Healthcare-specific data focus and a continuous monitoring approach as described by the vendor	Configurable applications and workflow focus, with a longer market presence in configurable GRC	Large vendor scale, broad suite coverage, and integrations across governance and audit functions
Key Constraints	Limited independent reviews publicly available; limited public IT/security detail beyond SOC 2 and HIPAA alignment; niche focus may not match non-provider needs	Implementation and design work required; pricing and total cost of ownership not transparent	Can be heavyweight/complex; implementation and cost may be substantial

01Competitive Landscape

Narrative competitive analysis

Potential advantages for 1m: the vendor’s healthcare-specific dataset and the framing of risk in financial and strategic terms could differentiate the product when compared with generic GRC platforms, particularly for functions focused on finance and strategy alignment.
Where alternatives may have advantages: established GRC platforms often publish more detailed security documentation, have larger numbers of third-party reviews, broader framework coverage, and more extensive partner ecosystems.

Market adoption signals

	1m	LogicGate Risk Cloud	Diligent (GRC platform family)
Starting Price	Not publicly disclosed (enterprise quote)	Not publicly disclosed (custom pricing on request)	Not publicly disclosed (quote-based for enterprise GRC suites)
Intended For	Health systems seeking healthcare-specific risk intelligence and quantified exposure linked to finance/strategy	Organizations seeking configurable GRC workflows across industries; users who want customizable applications	Organizations requiring a broad governance, risk, and compliance suite integrated with board governance and audit workflows
Key Differentiator	Healthcare-specific data focus and a continuous monitoring approach as described by the vendor	Configurable applications and workflow focus, with a longer market presence in configurable GRC	Large vendor scale, broad suite coverage, and integrations across governance and audit functions
Key Constraints	Limited independent reviews publicly available; limited public IT/security detail beyond SOC 2 and HIPAA alignment; niche focus may not match non-provider needs	Implementation and design work required; pricing and total cost of ownership not transparent	Can be heavyweight/complex; implementation and cost may be substantial